3rd Annual Pharma Supply-Chain & Security World 2020
2020-04-01 - 2020-04-02
The Annual Pharma Supply Chain and Security World Summit is back in London for the 3rd time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit, diverted, and adulterated drugs entering into the supply chain.
To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma Supply Chain & Security World 2020 – Supply-chain, Drug Serialization And Anti-Counterfeiting conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference you’ll not only discover innovative technologies, transformation strategies and collaboration methods, but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting.
To learn more and to register online, visit: http://bit.ly/2lB3X2E

4th Advanced Sourcing R&D Procurement in Pharma Summit
2020-04-07 - 2020-04-09 | The Colonnade Hotel, 120 Huntington Ave, Boston, MA, 02116, United States
Join the 4th Advanced Sourcing R&D Procurement in Pharma Summit to: Discover How Can R&D Procurement Enhance SRM, Expedite Speed-to-Market & Deliver Beyond TCO. As the only meeting catered to the needs of senior R&D Procurement, Sourcing and Category Management leaders, we have seen the transformation since we launched this meeting in 2017. Over the last 3 years, we have witnessed the industry begin to mature – procurement leaders play an increasingly important role as strategic business partner and innovation enabler, supporting R&D to progress into clinic and commercialization.
Be part of this growing community where you can share your common challenges and be inspired by fellow colleagues from pharma and biotech. Find out more > https://ter.li/8mwudk

Temperature Controlled Logistics in Biopharmaceuticals US
2020-04-08 | Virtual Event
Temperature Controlled Logistics in Biopharmaceuticals US 2020 is going virtual!
Now in its 4th year, Temperature Controlled Logistics is going VIRTUAL to deliver key, actionable insights into very latest regulatory requirements, technological innovations, strategic developments, and how to implement them into your commercial and clinical logistics with both maximum efficiency and minimal cost.
Temperature Controlled Logistics will bring you everything you need to ensure a successful and compliant implementation for storage and distribution. With a more interactive and hands on agenda including panel discussions; roundtables; speed networking; think tanks; mini workshops and more, this event will create an environment where storage and distribution teams from across all sizes of manufacturer can work together to manage creative, technical, and regulatory demands while ensuring patients are safeguarded at all stages.
Join pharmaceutical, medical device and biotechs experts to discuss new trends and opportunities and learn how to optimize temperature maintenance with the supply chain.

eyeforpharma Philadelphia Virtual
2020-04-14 - 2020-04-17 | Online, PA
“As we self-isolate, we must be careful not to isolate our ideas and thoughts. Ironically, it has never been more important for our industry to share, collaborate and inspire. For that reason, we have not cancelled the eyeforpharma Philadelphia meeting, but we’re moving it online. It is also now entirely free of charge to attend. I’m humbled that the speakers and supporters that were due to present are moving online with us, and share with us a desire to ‘do what we can’ to make sure that we carry on communicating. I believe the event will be stronger than ever, and more influential – at just the right time.”

Paul Simms, Chairman, eyeforpharma
Why eyeforpharma Philadelphia Virtual is essential viewing:

It’s free for all to join: In such a difficult time, we want to unify the industry and we’ve taken the decision to allow anyone to sign up to listen live, ask questions and participate. If you work for a pharma or biotech, you’ll also get access to a full meeting service so you can set up bespoke 1-1 meetings with fellow attendees.

A speaker faculty even better than before: You’ll learn from 100+ speakers with 60+ free sessions – presentations, panels, fireside chats, interactive workshops and Q&A, You’ll also see hours of additional live and on-demand content, including never-before-seen interviews with Kabir Nath, President & CEO North America, Otsuka, Julie Gerberding, EVP and Chief Patient Officer, Communications, Global Policy and Population Health, Merck, James Musick, VP and Head of Digital Transformation, Neurology, UCB, and many more.

Connect with industry leaders around the world: Without the constraints of geography, we’ll have thousands of industry leaders from across the globe coming together to network and collaborate.

Complete virtual meetings platform: Send messages to connect 1-on-1 with your fellow attendees. Schedule meetings and use a virtual private meeting room to chat.

Full virtual exhibition: Showcasing over 50+ exhibitors, search for the latest services and technology solutions from your desk, watch demo videos and the ability to share your virtual business card.

Register for FREE here: https://bit.ly/2UPFCVZ Join the conversation and become healthcare’s solution.

Neuroimmunology Drug Development Summit 2020
2020-04-15 - 2020-04-17 | The Colonnade Hotel, 120 Huntington Ave, Boston, MA, 02116, United States
More and more pharma and biotech companies are investing in research focused on neuroimmunology and neuroinflammation’s relation to neurodegenerative diseases in the challenge to develop clinically effective therapeutics.

The 2nd Neuroimmunology Drug Development Summit’s agenda has specifically designed alongside neuroimmunology experts from the likes of Denali, AbbVie and Biogen to help these drug developers to overcome their translational challenges and successfully translate their drug candidates into the clinic.
Immerse yourself in the field’s cutting-edge scientific advances and take this unrivaled opportunity to join over 23 expert industry speakers and over 80 drug developers from the neuroimmunological community for over 7 hours of dedicated networking time and 2 deep-dive workshops.
To find out more and view the full speaker line-up, download the full event guide.

2nd Digital Health for Pharma (DH4P)
2020-04-20 - 2020-04-22 | Philadelphia, PA, Philadelphia, PA, United States
Digital Health for Pharma (DH4P) is the leading Digital Health conference specifically developed for pharmaceutical and life science commercial organizations. Co-created by Evolution Road and ExL Events’ Digital Pharma Series teams, the three-day event serves to educate life science organizations on how best to leverage digital tools to enhance the commercial model of health and pharma; while also educating patients and bridging the gap between knowledge and information, pre-commercial and commercialization.

For 2020, ExL Events and strategic partners at Evolution Road explore five core leverage models of learning:

INVEST
INCUBATE/ACCELERATE
COMMERCIALIZE
COLLABORATE
CO-DEVELOP

Learn more: http://bit.ly/2TJ2cOh

9th Digital Marketing for Medical Devices West
2020-04-22 - 2020-04-24 | San Francisco, CA, San Francisco, CA, United States
Digital Marketing for Medical Devices is the premier event in the west coast for medical device companies to explore best practices and innovations to improve their digital marketing strategy. Med device companies will hear from their peers in the industry as well as marketing agencies who will reveal the most effective methods to market their products in a digital age.

The event takes place in San Francisco, one of the largest tech hubs in the world, as the medical device industry in this region is expanding at a rapid pace. DMMD West provides a platform to assist this rapid expansion. From innovation through research and development, marketing and data analytics, communication and branding strategies, and measuring KPIs and ROIs, this event serves to assist your organization, small and large, along your product life cycle.
Learn more: http://bit.ly/39xKlke

Manufacturing Assets & Facility Management in Pharma
2020-04-28 - 2020-04-30 | Wyndham Boston Beacon Hill 5 Blossom Street Boston, MA, MA 02114, United States
Pharma, biotechs and CMOs have witnessed a major transformation with the continued adoption of digital manufacturing and emerging technologies using AI and big data. We have seen pioneers, including the likes of Sanofi and Merck, to maximize asset value, increase plant reliability and ensure production continuity through digitization.
The inaugural Manufacturing Assets & Facility Management (MAFM) in Pharma Summit has been specifically designed to help you manage cost pressures and boost productivity through digitization where you will advance various aspects of asset and facility management programs such as clarity of asset inventory, asset lifecycle, facility footprint and sustainability.

Why is this Event for You? Join this cutting-edge discussion to:

Get up to speed with the digital transformation to streamline operations
Find new approaches to strategic asset management to improve inventory visibility
Use data to enhance asset utilization and track the full lifecycle of assets
Employ energy and sustainability initiatives to reduce utilities spend
Manage MRO processes to improve productivity and reduce costs

Immerse yourself in this industry-led meeting with the likes of Merck, CSL Behring and Seattle Genetics. This event is dedicated to exploring strategies in the manufacturing environment where you will join 60+ senior experts from functions of Manufacturing Engineering, Manufacturing Operations, Facility Management, Asset Management, Procurement and Maintenance & Reliability across pharma, biotech and CMOs.
Register with your team today and don’t miss out on this unique meeting to engage with peers and re-define best practice for tomorrow’s operations.

Recombinant Chromogenic Assay as Alternate Methods for the Bacterial Endotoxins Test (BET)
2020-04-29 | WEBINAR
Recombinant Chromogenic Assay as Alternate Methods for the Bacterial Endotoxins Test (BET)
Conference: 29 April 2020 – 10am EDT (3pm BST – UK time)
Location: WEBINAR
Website: https://www.smi-online.co.uk/pharmaceuticals/webinar/recombinant-chromogenic-assays
HOSTED BY: Associate of Cape Cod
LED BY: Veronika Wills, Manager, Technical Services, Associates of Cape Cod

Recently, there has been a lot of interest associated with the potential use of synthetic (non-animal based) reagents for bacterial endotoxin testing. This webinar will provide an in-depth overview of the global perspective on the use of such reagents, including their regulatory status.
This free to join webinar is sponsored by Associate of Cape Cod, the one hour webinar will focus on executing a recombinant kinetic chromogenic assay, testing samples and detailed data interpretation with the primary focus on comparability of the data with conventional amoebocyte lysate- based assays.
BENEFITS FOR JOINING THE WEBINAR:
This interactive webinar will provide the following benefits:

An overview of global status of recombinant reagents for BET
A session on kinetic chromogenic testing
Data interpretation
Troubleshooting kinetic chromogenic assays
Equivalency of the recombinant reagents to LAL reagents

WHO SHOULD JOIN?

Senior Microbiologists
Lead Scientists
Laboratory Managers
QA Specialists
Drug Substance External Manufacturers
QC Scientists
Heads of Quality
Business Development Managers
Pharmaceutical Microbiology Consultants
Higher Pharmacopoeia Scientists
Analytical Standards Specialists

For full details and to register your free place, please visit: https://www.smi-online.co.uk/pharmaceuticals/webinar/recombinant-chromogenic-assays

NASH Summit Boston
2020-05-04 - 2020-05-07 | 50 Park Plaza at Arlington Street, Boston, MA, 02116-3912, United States
The NASH Summit offers a wide range of cutting-edge debates across 4 conference tracks: discovery, translational, non-invasive biomarker and clinical drug development, in addition to a selection of workshops and seminars. This convivial discussion and networking forum has an extensive program set to help you approach your pipeline for the upcoming year.

Join 80+ speakers, including our conference Chair Jason Campagna, Senior Vice President & Global NASH Lead at Intercept, and 350+ attendees as the community comes together again by addressing their challenges and the consequences of change in the NASH market.

Establish a plan of action to optimize candidate success by evaluating advances and difficulties and learn from the community’s experience
Translate anti-fibrotic efficacy into the clinic by learning about ground-breaking preclinical modalities
Use the latest practical insights into hepatocyte differentiation to improve your target identification by understanding its impact on immune cells, ductular reaction and fibrosis
Examine the payer’s thoughts on the need to biopsy and assess the clinical utility of non-invasive diagnostics in the normal algorithm of care
Connect NASH reduction in phase 2 and NASH resolution in phase 3 while justifying a systemic approach to address NASH in combination, as a manifestation of wider metabolic dysfunction

Download the full event guide or get in touch today for the agenda and speaker line-up!

SMi’s 20th Annual Pain Therapeutics Conference
2020-05-11 - 2020-05-12 | REMOTE ACCESS ONLY
SMi’s 20th Annual Pain Therapeutics Conference
Discover Cutting Edge Research and Novel Therapeutics in the Pipeline
Conference: 11 and 12 May 2020
Location: REMOTE ACCESS ONLY
Website: http://www.pain-therapeutics.co.uk/PharmaJournWL
Announcement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only – please register your place at www.pain-therapeutics.co.uk
The price to be a part of this conference is £999 (remote access) and registration is available via the conference website at www.pain-therapeutics.co.uk
The 20th Annual Conference will overview the current state of pain treatment starting with research essentials including choosing the right preclinical models to overviewing clinical success up to date, highlighting cutting-edge research and evaluating the potential of drug candidates in the pipelines of leading pharmaceuticals.

This year we are introducing the Pain Research Essentials theme to closely observe analgesics drug development from a preclinical point of view. Within this theme talks will address the latest biomarker discoveries, bridging the translational gap, differences of pain pathology across sexes and consequently, the need for distinct gender animal models. This will be topped with a panel discussion around novel drug targets in neuropathic pain treatment.
Presentations on clinical stage research will highlight current struggles of opioid-based treatments and discuss results of treatments with non-opioid targets; such as the recently researched cannabinoid receptor 2, nociception/orphanin FQ peptide (NOP) receptor, ENKephalinase and NGF receptors. Furthermore, neuro-immune interactions and their role in pain pathology will be discussed as an anticipated approach for providing more effective therapy for chronic pain. Additionally, the therapeutic efficacy of neurotoxins will be addressed exploring novel botulinum-based constructs.
Join SMi’s leading Pain Therapeutics Conference which will explore the cutting-edge research of novel therapeutics in the pipeline of leading pharmaceutical companies and discuss solutions for the challenges of understanding pain as a heterogenous disease and the diverse treatment approaches it requires.
Event Hashtag: #SMiPain
View the full agenda: http://www.pain-therapeutics.co.uk/PharmaJournWL
WHO SHOULD ATTEND
Chief Executive Officer, Chief Scientific Officers, Chief Medical Officers, Managing Directors, CEO, Head of Department, Principal Research Scientists, Clinical lead, Clinical Operations in the following fields:

Pain and Migraine
Inflammation
Chronic Pain
Neuropathic Pain
Analgesic pre-clinical development
Anaesthesia and Pain Management
CNS clinical trials
Ion Channel Pharmacology
Pharmacology Intelligence
Translational science
Drug development
Exploratory development

EARLY BIRD-RATES

BOOK BY 28TH FEBRUARY AND SAVE £200
BOOK BY 31ST MARCH AND SAVE £100

Highly Potent Active Pharmaceutical Ingredients (HPAPI)
2020-05-11 - 2020-05-12 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020.
Announcement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only – please register your place at www.highlypotentapi.com
The price to be a part of this conference is £999 (remote access) and registration is available via the conference website www.highlypotentapi.com

HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
Attend the conference and join our networking platform for industry professionals to provide you with the expertise to overcome the challenges of the HPAPI industry.
Network and learn from leading professionals such as:
CHAIR FOR 2020 – Justin Mason-Home, Director, HPAPI Project Services Limited
KEY SPEAKERS INCLUDE:
Pascal Michoux, Vice President, Global EHS Teva api & Biologics, teva API Italy
William Hawkins, Manager Occupation Toxicology, GsK
Brian Edwards, Chair, Pharmaceutical Human Factors Group, CIeHf
Thomas Adam, Head of GQA Chemical APIs, Bayer AG
Ildikó Ziegler, QA Manager, Gedeon Richter
Francois D’Hooge, ADC Project Manager, Gamamabs Pharma
Andreas Schreiner, Head of Validation, Novartis
FEATURED HIGHLIGHTS:

Explore HPAPI manufacturing with 8 big pharma from both the toxic substance and the employees’ perspective
Gain better understanding of human factors and ergonomics aspects and their role in improving production performance with the Chartered Institute of Ergonomics and Human Factors
Deep dive into the oncology market and ADC production, the main driver of the HPAPI industry
Learn what it takes to create a safety company culture and how to better train your employees on risk perception

View the full agenda: www.highlypotentapi.com
Contact Info:
T: +44 (0) 20 7827 6164
E: nhoward@smi-online.co.uk

4th Annual Global Clinical Trials Connect 2020 - Collaboration, Innovation and Enhancing Quality in Clinical Trials
2020-05-13 - 2020-05-14 | Holiday Inn London – Kensington High St. Wrights Ln, Kensington, London W8 5SP, UK
The 4th Annual Global Clinical Trials Connect 2020 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.
Key Highlights

Patient Recruitment and Site selection
Innovative trial designs
Partnership & Collaboration – Sponsors, CROs, Sites and External Vendors
Patient centric clinical trials
New innovations in Patient Recruitment planning and execution on a clinical trial
Outsourcing strategies and models
Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome
Streamlined IRT development process
Pharmacovigilance & Clinical Trials
Post-Clinical Trial closed communities
How to future proof your clinical operations
Implementing Risk Based Monitoring
Streamlining R&D and lower costs in clinical trials
Adaptive Trial Model
Clinical Trial Auditing
Real World Clinical Trial Strategies
Data Quality & Technology
Clinical Data Strategy & Analytics
Clinical Technology and Driving Innovation
M-Health, Wearable and Consumer Technology
Big-Data, IoT and Artificial Intelligence Technology in Clinical trials
Blockchain technology for improving clinical research quality

Outsourcing in Clinical Trials East Coast
2020-05-19 - 2020-05-20 | Valley Forge Casino Resort – 1160 1st Ave, King of Prussia, PA 19406, United States
Discover effective strategies for outsourcing clinical trial operations to ensure studies run smoothly and within budget

Arena International are delighted to announce Outsourcing in Clinical Trials East Coast will be returning to King of Prussia in May for its 11th Annual event!

The 2020 programme will feature a range of speakers from the likes of GlaxoSmithKline, Novartis, Pfizer, BMS any many more, who through a variety of interactive session formats will offer insight on promoting successful collaboration between the clinical trials community. Attendees will have the opportunity of taking part in sessions across 3 stages, each focusing on a different topic area. Whether your role is Clinical Operations, Technology & Innovation or Clinical Data Management this event can not be missed

We look forward to seeing you there!

Digital Health Online Summit
2020-05-25 - 2020-05-30 | Online
The healthcare industry will never be the same after COVID19.
Healthcare professionals need to stay aware of the latest digital health activities and keep learning from leading organizations.

Digital Health Online Summit is a 6-day virtual summit, providing a comprehensive overview of the current digital health activities, and equipping health professionals with strategies and tactics, examples and guidelines for a successful healthcare transformation.
This online summit will provide you with timely insights into the following areas:

Digital Health – Current Activities in different organizations
Smart Care, Patient Centricity and Engagement
Transformation with VR/AR, Voice Tech, IoT, Wearables
Big Data, AI and Machine Learning
The digital mindset transformation
Patient staff engagement and culture change
New Horizon, Innovation and Tomorrow’s Perspectives

Within each topic, there will be 5-9 speaking sessions, using case studies and bringing practical examples. The summit will gather 40 expert speakers from great companies and associations from all around the world, including Europe, North America and Australia.
While the standard events require a lot of time, effort, logistics, and significant expenses for travel and accommodation, Digital Health Online Summit takes advantage of today’s technologies and provides the best content for professionals from all around the world.
To mention just some of the speaker’s companies: United Health Group, HNS, Dignity Health, European Health Management Association, WONCA, Stanford Virtual Human Interaction Lab, XpertCare Inc., Seton Health Alliance, Deloitte, KPMG, Mednax, Crossroads Hospice & Palliative Care, CitiusTech, Partners HealthCare, Peninsula Regional Health System, Philips, Ramsay Santé and others.
This is a great possibility to learn directly from C-Suite executives with unique and timely insights about the digital shift towards better health services.
Here are just some of the case studies and presentations:
➤ Visions and Strategies for Virtual care services
➤ Current Challenges of Digitalization in the Healthcare Industry
➤ Key components of a successful digital transformation strategy
➤ How to keep the conversation open with HCPs while they are not available (COVID-19 crisis time)
➤ Frontline digital healthcare strategy – from business as usual to crisis management
➤ Digital when possible – physical when needed
➤ Personalized, digitally-supported, out- of-hospital care: A patient case study
➤Digital Therapeutics: Just Like a pill?
➤ Innovation in times of a global crisis
And much, much more.
For our members and network, we have FREE REGISTRATIONS to this great online summit.
Get your FREE PASS here >> https://www.digitalhealthonlinesummit.com/?utm_source=partner
Hope you can join the event!

Microbiome Connect: Human
2020-06-03 - 2020-06-04 | Boston, MA, MA, United States
Previously known as North American Microbiome Congress, Microbiome Connect: Human USA is all about connecting leading academics and biotech companies presenting preclinical and clinical data, to network, educate and share knowledge. Join key opinion leaders and 50+ expert speakers across three dedicated tracks of content to examine the latest preclinical and clinical data in extra-intestinal and intestinal indications.
To know more about Microbiome Connect: Human please click here.

Microbiome Connect: Skin
2020-06-03 - 2020-06-04 | Boston, MA, USA
Microbiome Connect: Skin | 3 – 4 June 2020 | Boston, USA

2019 was a pivotal year for the skin microbiome, with multinational conglomerates moving into the space, recognizing the commercial value of skin microbiome-based products as the next step in a consumer’s skincare regime but the innovation doesn’t end there…
This year is all about the major advancements of sequencing and analysis in this space, and how we can use data to inform product development. 2020 is all about the relationship between skin microbiome based-products, skin conditions, personalization, skin-gut supplements, and anti-aging.
Building on the hugely successful global Skin Microbiome series which brought together over 600 industry leaders from Pharmaceutical, Beauty and Personal Care, Independent Skincare Brands, Bio-techs, Researchers and Academics, Kisaco Research presents Microbiome Connect: Skin USA, an all-encompassing event, which runs alongside Microbiome Connect: Human USA in Boston, June 3 – 4.
To learn more about this event and to register online, visit http://bit.ly/3a9rICR

HR Life Science Virtual Event
2020-06-04 | Online, Noon EST
The HR Life Sciences Virtual Event is a WFH friendly forum covering a range of topics affecting HR strategy and talent management, including telework, employee communication, training or re-training – and of course crisis management as we navigate these unchartered waters. We want to provide you with insights and resources from your peers working through unprecedented challenges at their organizations.
Whether your current work environment is a home office, kitchen table, or hiding from the kids in your bathtub, you can join HR leaders from a diversity of pharma, biotech and medical device companies (whether live or at your own pace!) as we chat through front-of-mind topics and solutions.

ACI’s Skin Microbiome Industry Summit
2020-06-17 - 2020-06-18 | London, UK, United Kingdom
Skin microbiome products have been gaining more momentum in the last few years with more brands starting to develop products, and personal care giants either starting to develop their own product or investing in start-ups focusing on these. It is a very exciting time for companies looking into this at the moment, figuring out not only product development & formulation but also marketing strategy to raise more attention to this type of products. Despite huge popularity and early success stories, there is still a need to learn more on topics such as: defining the skin microbiome, formulating products, cosmetics & pharma claims, regulation for novel products, latest advances in terms of mapping & profiling technologies, as well as product testing.

ACI’s Skin Microbiome Industry Summit, taking place on the 17th & 18th June 2020 in London, will bring together the key actors of the industry to help the industry learn from one another, work together to further grow and create new business opportunities. During the 2 days conference, the participants will enjoy the various case studies presentations, panel discussion, Q&As and networking breaks to get the industry to thrive together. Join us in London for a highly interactive & informative conference, whilst enjoying the networking opportunities with your peers.

CPhI & P-MEC China 2020
2020-06-22 - 2020-06-24 | Shanghai New Int’l Expo Centre (SNIEC), 2345 Longyang Road, Shanghai, China
CPhI & P-MEC China is your gateway to successfully grow your business at the 2nd largest pharma market in the world and your ONE-STOP SHOP pharmaceutical platform connecting the entire pharmaceutical industry chain. On 22-24 June 2020, CPhI China 2020, collocated with ICSE China, NEX China, and P-MEC China, will continue its glorious journey and celebrate its 20th anniversary at Shanghai New International Exhibition Centre (SNIEC). The show is to cover an exhibition area of 210,000 sqm and is expected to draw 3,400+ exhibitors from over 140 countries and regions and 75,000+ visits from global industry professionals.
To learn more about CPhI & P-MEC China and to register online, visit www.cphi-china.cn/en

JAK Inhibitors Drug Development Summit – Running Digitally for 2020
2020-06-24 | Online
Despite the increasingly unpredictable nature of COVID-19, our commitment to provide educational resources and networking experiences to keep pharmaceutical knowledge thriving and the industry moving forward has not wavered.

Therefore, we are very excited to announce that the JAK Inhibitors Drug Development Summit has been transformed into an exclusive one-day digital event that will immerse you in discussions on developing the next generation of JAK inhibitors to expand their clinical utility across oncology, dermatology and autoimmune disease indications.
This is your one and only cross-disciplinary JAK inhibitor meeting with all the content and networking opportunities now delivered in a digital format.
Our community of JAK inhibitor experts are looking forward to connecting with you in the digital world, including:

Leandro Santos, Associate Director, Clinical Sciences Incyte
Maciej Wieczorek, Chief Executive Officer, Celon Pharma
Piet Wigerinck, Chief Scientific Officer, Galapagos
Anabela Cardoso, Global Brand Development, Lead – Immunology, Eli Lilly
Brett King, Associate Professor of Dermatology, Yale School of Medicine
Massimo Gadina, Chief Translational Immunology Section, National Institute of Arthritis & Musculoskeletal & Skin Diseases

Don’t miss this opportunity to hear about the latest data shared by peers, and take advantage of the online networking and ‘Ask the Expert Speaker’ chatrooms.
Visit the website to learn more and secure your place: https://ter.li/o6ghqw

Onco Cell Therapy Summit
2020-07-07 - 2020-07-09 | Virtual, EDT Timezone
Onco Cell Therapy Summit (OCTS), formerly the CAR-T Congress, is the leading digital event revolutionizing patient outcomes in cancer therapies.
This virtual summit, taking place June 7 – 9, spans across 3 half days, bringing you opportunities to share novel research, manufacturing techniques and regulatory best practice through virtual panel discussion, traditional presentations, polls and round tables, all from the comfort of your own home. Each session at OCTS 2020 is dedicated to encouraging knowledge sharing and translating novel data assets and IP into commercially viable oncological therapies.

OCTS is a 4-track event and whilst bringing together the key decision makers for CAR-T therapies, it also focuses on ground breaking science that is driving the surge of interest in harnessing alternative cell therapies in cancer treatments.
With 2 of our tracks comprised of research on CAR-T and alternative cell therapies, the other pillar in rolling out these therapies is increasing the affordability of the treatments. The other two tracks will delve into best practice in commercialization and manufacturing of immuno-oncological cell therapies.
Each day includes plenty of opportunities to network and there’s multiple panel discussions to also take a deep dive into the key challenges in major topics to R&D, manufacturing and commercialization.
This is one must attend virtual event in the cell therapy field.

Direct to Patient and Virtual Clinical Trials – Digital Experience
2020-07-09 | Virtual Event
With COVID-19 creating worldwide disruption in clinical trials and companies looking for innovative approaches to keep trials going, we at Arena International are delighted to announce the launch of our Direct to Patient and Virtual Clinical Trials Digital Experience.

This one-day online event will bring together top-class speakers from around the world to discuss themes including remote monitoring, temperature control in direct-to-patient shipments, regulations and compliance, and how to engage patients throughout a virtual trial.
Alongside listening to presenters in our auditorium, attendees will have the opportunity to visit our virtual exhibition hall, chat in our networking lounge, and set up 1:1 business meetings.
This event will be a crucial platform for clinical trials professionals to learn about how to adapt to direct-to-patient and virtual trials in a COVID and post-COVID world, making it an unmissable event in your calendar.

Clinical Operations In Oncology Trials
2020-07-15 | Vitual Event
To keep pace with the health needs of the growing number of young and old afflicted with cancer globally, clinical development in oncology is one of the fastest growing areas within the Pharma industry. At this unique virtual event, attendees will get to learn strategies to better manage communication and relationships between trial sponsors and CROs, learn ways to create patient-centric trials for higher enrolment rates including addressing the need for more diverse recruitment and much more. Key presenters on the line-up consist of C-level and director-level executives from the likes of Tufts Medical School, Beat AML, Pfizer and Agios Pharmaceutical.
URL: https://arena-international.com/oncologyvirtual/

Gene Therapy for Neurological Disorders Europe
2020-07-15 09:00 - 18:15 (Europe/Paris)
Gene Therapy for Neurological Disorders Europe is dedicated to solving the translational drug development challenges encountered in the development of gene therapies for neurological disorders.

Industry pioneers from the leading pharma and biotech companies including Avexis, uniQure, and Biogen will share how to improve the translatability of small and large animal models, develop innovative delivery approaches to guarantee delivery of vector and understand the realities of immunogenicity challenges in the CNS.
Join this definitive, niche digital conference to accelerate the development of your gene therapy pipeline and address the significant unmet need in neurological indications.

Prefilled Syringe Elastomer Components - High-quality Solutions for Sensitive Molecules
2020-07-16 | Webinar
Join the experts on this free exclusive webinar on the 16th July 2020 at 2pm BST, hosted by West Pharmaceutical Services, Inc.
As the industry continues to see significant growth for drug products developed in prefilled syringe systems (PFS), there is a trend for pharmaceutical companies to evaluate more complex drug molecules, such as biologics.
This webinar discusses current trends in the market for injectable drug delivery and outlines current challenges for companies developing drug products in a prefillable syringe system.

Webinar Overview
Increasing demands on quality, stringent regulations, trends towards home care treatments by using innovative device technology, and the development of specialized, high-value treatments present challenges to companies looking for unique solutions.
In this webinar we will cover new elastomer component leading with innovation excellence developed to address the ever-increasing demands. Discussing the challenges of the pharmaceutical industry driven towards components being essentially free of particulate and meeting customer demand for consistency by assuring dimensional stability.
For more information on the webinar and to register your free place, please visit: www.pfs-elastomer-components-webinar.com/mp

Medical Device Trials
2020-07-16 | Virtual Event
At our first Medical Device Trials virtual event our aim is to support trial sponsors and solution providers internationally to ensure trials are delivered on time, partnerships are improved and innovations are showcased, discussing, deliberating and debating the latest operational and technological challenges with regards to clinical trial in medical devices. Hear talks from Bassil Akra, Faouzi Kallel from Edwards Lifesciences and many other industry leaders and disrupters!
URL: https://arena-international.com/ctmd/

EXCLUSIVE FREE WEBINAR ON Prefilled Syringe Elastomer Components High-quality Solutions for Sensitive Molecules
2020-07-16 | Webinar
Join the experts at this free exclusive webinar on the 16th July 2020 at 2pm BST, hosted by West Pharmaceutical Services, Inc.We have had over 90 registrations so far, joining us from:Abbvie, Aptar, Aptar Pharma, BI Pharma GmbH & Co. KG, BioQ Pharma Inc, Datwyler, DEKRA, Hikma Pharmaceuticals, j8 Process Consulting Taiwan, Janssen, Kansai Plascon, Lazard, Lilly, Nemera, Novartis, Ohio State University, Pfizer Inc, Regeneron, Roche, Sanofi, Sanofi Pasteur, Schott, SCHOTT France, Sio2 Materials Science, Softeq, Sumitomo Rubber North America, Sun pharma research center, TUV Italia srl, TUV Italy, Vetter Pharma-Fertigung GmbH & Co. KG, Weiss-Aug Co, Inc., WL Gore, Zacros (Fujimori Kogyo co. ltd.) and many more!
With only less than 2 weeks to go, if you haven’t already registered your FREE place book your virtual seat here today!Can’t make the date/time? Register your place at the above link and we will send you the webinar, post event.
Webinar OverviewIncreasing demands on quality, stringent regulations, trends towards home care treatments by using innovative device technology, and the development of specialized, high-value treatments present challenges to companies looking for unique solutions.In this webinar we will cover new elastomer component leading with innovation excellence developed to address the ever-increasing demands. Additionally, we discuss the challenges of the pharmaceutical industry driven towards components being essentially free of particulate and meeting customer demand for consistency by assuring dimensional stability.Expert Webinar Hosts from West Pharmaceutical Services, Inc.Christa Jansen-Otten,Product Management, Prefilled Systems & DeliveryWhitney Winters,Senior Director, Strategic Marketing and container SystemsFind out more information on the webinar hosts here.
For more information on the webinar and to register your free place,
please visit: www.pfs-elastomer-components-webinar.com

Innate Immune Stimulating Therapies Summit – Running Digitally for 2020
2020-07-22 | Online, MA
Safely Harnessing Novel Targets of the Innate Immune System for Enhanced Anti-Tumor Effects
The inaugural Innate Immune Stimulating Therapies Summit is focused on achieving safe and effective clinical and commercial translation of STING and TLR therapies.

Join the leaders in the field, from key biotech, large pharma, and academia, to discuss how to optimize the administration of innate immune stimulating therapies from IT delivery through to antibody conjugated approaches.
If you are looking to make long lasting connections with industry leaders and take part in discussions about the lessons learned on the journey to translating safe and effective innate immune stimulating therapies for patients in need, then this is the meeting for you. Join our online community of industry experts here: https://ter.li/52s56v. Earlybird and group discounts apply. Book early to secure the best possible rate on your ticket.

RNAi-Based Therapeutics Summit – Running Digitally for 2020
2020-07-22 | Virtual Event
Digitally Join the RNAi-Based Therapeutics Community
We are excited to announce that the RNAi-Based Therapeutics Summit has gone virtual!
As the first multi-disciplinary discussion for large pharma, biotech and academic leaders specifically dedicated to the RNAi therapeutics, the industry will be coming together on Wednesday, July 22 to successfully optimize cell-specific strategies, overcome pharmacology and delivery challenges to accelerate translation and clinical development of RNAi therapeutics in the liver, CNS and beyond.
Check out the official event guide for full speaker and session details.
Join this virtual summit to meet those pioneering the field and to hear from 19+ world-class experts that are sharing their latest perspectives:

Dong-ki Lee, Founder & Chief Executive Officer, OliX Pharmaceuticals
Elena Feinstein, Chief Scientific Officer, Quark Pharmaceuticals
Karyn O’Neil, Chief Scientific Officer, Aro Biotherapeutics
Brooke Rock, Director, Amgen
Sharmistha Ghosh, Associate Director, Arrowhead Pharmaceuticals
Baisong Mei, Senior Global Project Head, Sanofi
David Corey, Professor, UT Southwestern

Download the updated program to see the full list.
With several clinical candidates emerging and momentum building in the field, join the RNAi-Based Therapeutics Summit – your comprehensive, industry-focused virtual meeting dedicated to bringing together senior biopharmaceutical leaders from discovery, translation, and clinical development functions to advance pioneering RNAi platforms that improve patient outcomes. Secure your ticket now.
Looking forward to seeing you at our virtual meeting!
